Literature DB >> 35918606

Chair stand test as a proxy for physical performance and muscle strength in sarcopenia diagnosis: the Korean frailty and aging cohort study.

Ji Yeon Ryu1, Miji Kim2, Kyoung Soo Kim1, Sunyoung Kim3, Chang Won Won4.   

Abstract

BACKGROUND: The 5-times chair stand test (5CST) is a proxy tool for measuring physical performance and muscle strength in diagnosing sarcopenia. The Asian Working Group for Sarcopenia 2019 guidelines recommends the 5CST for evaluating gait speed, whereas the European Working Group on Sarcopenia in Older People guidelines recommend the chair stand test as a proxy for muscle strength. AIMS: This study sought to determine whether the chair stand test correlates with handgrip strength and gait speed, and investigate sex differences in these relationships.
METHODS: We used data collected from 1416 participants (678 men and 738 women) in the 2017 Korean Frailty and Aging Cohort Study (KFACS).
RESULTS: The 5CST time had a higher correlation with gait speed (r =  - 0.470) than handgrip strength (r =  - 0.309). In addition, 5CST time predicted low gait speed (area under the curve [AUC] 0.727) better than low handgrip strength (AUC 0.641). The optimal cutoff values of the 5CST to estimate low gait speed were 10 s for men (sensitivity 62%, specificity 64%) and 11 s for women (sensitivity 68%, specificity 67%). The optimal cutoff values of the 5CST for low handgrip strength were the same as those for low gait speed (10 s for men and 11 s for women).
CONCLUSIONS: The 5-times chair stand test fits with gait speed and handgrip strength but seems to be a better proxy of gait speed than handgrip strength. The optimal cutoff values of the 5CST to estimate low gait speed and low handgrip strength were lower in men than women. Although none of the AWGS 2019 or EWGSOP guidelines present sex-specific cutoffs for the 5CST, it needs to be considered in the next guidelines.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Chair stand test; Gait speed; Handgrip strength; Muscle strength; Physical performance; Sarcopenia

Year:  2022        PMID: 35918606     DOI: 10.1007/s40520-022-02172-2

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   4.481


  28 in total

1.  Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.

Authors:  Ho Cheol Hong; Soon Young Hwang; Hae Yoon Choi; Hye Jin Yoo; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Hepatology       Date:  2014-03-24       Impact factor: 17.425

Review 2.  Clinical relevance of sarcopenia in chronic kidney disease.

Authors:  Ranjani N Moorthi; Keith G Avin
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-05       Impact factor: 2.894

Review 3.  Clinical definition of sarcopenia.

Authors:  Valter Santilli; Andrea Bernetti; Massimiliano Mangone; Marco Paoloni
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

4.  Prevalence of sarcopenia in community-dwelling older adults using the definition of the European Working Group on Sarcopenia in Older People 2: findings from the Korean Frailty and Aging Cohort Study.

Authors:  Miji Kim; Chang Won Won
Journal:  Age Ageing       Date:  2019-11-01       Impact factor: 10.668

5.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.

Authors:  Liang-Kung Chen; Li-Kuo Liu; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Kamaruzzaman Shahrul Bahyah; Ming-Yueh Chou; Liang-Yu Chen; Pi-Shan Hsu; Orapitchaya Krairit; Jenny S W Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Panita Limpawattana; Chu-Sheng Lin; Li-Ning Peng; Shosuke Satake; Takao Suzuki; Chang Won Won; Chih-Hsing Wu; Si-Nan Wu; Teimei Zhang; Ping Zeng; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2014-02       Impact factor: 4.669

Review 6.  Sarcopenia and the Common Mental Disorders: a Potential Regulatory Role of Skeletal Muscle on Brain Function?

Authors:  Julie A Pasco; Lana J Williams; Felice N Jacka; Nicole Stupka; Sharon L Brennan-Olsen; Kara L Holloway; Michael Berk
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

Review 7.  Sarcopenia: definition, epidemiology, and pathophysiology.

Authors:  Tae Nyun Kim; Kyung Mook Choi
Journal:  J Bone Metab       Date:  2013-05-13

Review 8.  Sarcopenia: etiology, clinical consequences, intervention, and assessment.

Authors:  T Lang; T Streeper; P Cawthon; K Baldwin; D R Taaffe; T B Harris
Journal:  Osteoporos Int       Date:  2009-09-25       Impact factor: 4.507

Review 9.  Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship.

Authors:  Jakub Mesinovic; Ayse Zengin; Barbora De Courten; Peter R Ebeling; David Scott
Journal:  Diabetes Metab Syndr Obes       Date:  2019-07-08       Impact factor: 3.168

Review 10.  Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview.

Authors:  Nana He; Yuelin Zhang; Lu Zhang; Shun Zhang; Honghua Ye
Journal:  Front Cardiovasc Med       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.